These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38011676)

  • 21. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a multiple marker test for ectopic pregnancy.
    Rausch ME; Sammel MD; Takacs P; Chung K; Shaunik A; Barnhart KT
    Obstet Gynecol; 2011 Mar; 117(3):573-582. PubMed ID: 21343760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. External validation of a simple scoring system to predict pregnancy viability in women presenting to an early pregnancy assessment clinic.
    Wan OYK; Chan SSC; Chung JPW; Kwok JWK; Lao TTH; Sahota DS
    Hong Kong Med J; 2020 Apr; 26(2):102-110. PubMed ID: 32245913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum calponin 2 is a novel biomarker of tubal ectopic pregnancy.
    Zhang R; Li S; Wang Y; Cai W; Liu Q; Zhang J
    Fertil Steril; 2021 Oct; 116(4):1020-1027. PubMed ID: 34217487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kisspeptin as a predictor of miscarriage: a systematic review.
    Silva PHAD; Romão LGM; Freitas NPA; Carvalho TR; Porto MEMP; Araujo Júnior E; Cavalcante MB
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2197097. PubMed ID: 37015836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.
    Allotey J; Snell KI; Smuk M; Hooper R; Chan CL; Ahmed A; Chappell LC; von Dadelszen P; Dodds J; Green M; Kenny L; Khalil A; Khan KS; Mol BW; Myers J; Poston L; Thilaganathan B; Staff AC; Smith GC; Ganzevoort W; Laivuori H; Odibo AO; Ramírez JA; Kingdom J; Daskalakis G; Farrar D; Baschat AA; Seed PT; Prefumo F; da Silva Costa F; Groen H; Audibert F; Masse J; Skråstad RB; Salvesen KÅ; Haavaldsen C; Nagata C; Rumbold AR; Heinonen S; Askie LM; Smits LJ; Vinter CA; Magnus PM; Eero K; Villa PM; Jenum AK; Andersen LB; Norman JE; Ohkuchi A; Eskild A; Bhattacharya S; McAuliffe FM; Galindo A; Herraiz I; Carbillon L; Klipstein-Grobusch K; Yeo S; Teede HJ; Browne JL; Moons KG; Riley RD; Thangaratinam S
    Health Technol Assess; 2020 Dec; 24(72):1-252. PubMed ID: 33336645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of serum human pregnancy-specific beta-1-glycoprotein 1 levels in pregnant women with or without preeclampsia.
    Temur M; Serpim G; Tuzluoğlu S; Taşgöz FN; Şahin E; Üstünyurt E
    J Obstet Gynaecol; 2020 Nov; 40(8):1074-1078. PubMed ID: 31790616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Risk Model for Predicting Fetuses with Trisomy 21 Using Alpha-Fetoprotein Variants L2 Combined with Maternal Serum Biomarkers in Early Pregnancy.
    Chen Y; Wu B; Chen Y; Ning W; Zhang H
    Reprod Sci; 2022 Apr; 29(4):1287-1295. PubMed ID: 34750768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of early pregnancy location and viability compared with hCG, progesterone and estradiol.
    Friis Petersen J; Grynnerup AG; Mitchell NH; Løssl K; Sørensen S; Lindhard A; Friis-Hansen L; Pinborg A; Nyboe Andersen A; Løkkegaard E
    J Reprod Immunol; 2020 Apr; 138():103103. PubMed ID: 32145561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers at 6 weeks' gestation in the prediction of early miscarriage in pregnancy following assisted reproductive technology.
    Guo J; Feng Q; Chaemsaithong P; Appiah K; Sahota DS; Leung BW; Chung JP; Li TC; Poon LC
    Acta Obstet Gynecol Scand; 2023 Aug; 102(8):1073-1083. PubMed ID: 37377341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia.
    Spencer K; Cowans NJ; Chefetz I; Tal J; Meiri H
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):128-34. PubMed ID: 17149788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of inhibin A and inhibin pro-alphaC in early human pregnancy and their role in the prediction of pregnancy outcome in patients with recurrent pregnancy loss.
    Al-Azemi M; Ledger WL; Diejomaoh M; Mousa M; Makhseed M; Omu A
    Fertil Steril; 2003 Dec; 80(6):1473-9. PubMed ID: 14667886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of beta 2-glycoprotein I-dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: correlation with conventional antiphospholipid antibody detection systems.
    Aoki K; Dudkiewicz AB; Matsuura E; Novotny M; Kaberlein G; Gleicher N
    Am J Obstet Gynecol; 1995 Mar; 172(3):926-31. PubMed ID: 7892887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies.
    Phipps MG; Hogan JW; Peipert JF; Lambert-Messerlian GM; Canick JA; Seifer DB
    Obstet Gynecol; 2000 Feb; 95(2):227-31. PubMed ID: 10674584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for spontaneous abortion in early symptomatic first-trimester pregnancies.
    Gracia CR; Sammel MD; Chittams J; Hummel AC; Shaunik A; Barnhart KT
    Obstet Gynecol; 2005 Nov; 106(5 Pt 1):993-9. PubMed ID: 16260517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A model and scoring system to predict outcome of intrauterine pregnancies of uncertain viability.
    Bottomley C; Van Belle V; Pexsters A; Papageorghiou AT; Mukri F; Kirk E; Van Huffel S; Timmerman D; Bourne T
    Ultrasound Obstet Gynecol; 2011 May; 37(5):588-95. PubMed ID: 21520315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
    Leandersson P; Åkesson A; Hedenfalk I; Malander S; Borgfeldt C
    PLoS One; 2020; 15(10):e0240418. PubMed ID: 33075095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accurate prediction of pregnancy viability by means of a simple scoring system.
    Bottomley C; Van Belle V; Kirk E; Van Huffel S; Timmerman D; Bourne T
    Hum Reprod; 2013 Jan; 28(1):68-76. PubMed ID: 23111205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum activin B concentration as predictive biomarker for ectopic pregnancy.
    Dhiman P; Senthilkumar GP; Rajendiran S; Sivaraman K; Soundararaghavan S; Kulandhasamy M
    Clin Biochem; 2016 May; 49(7-8):609-12. PubMed ID: 26968108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel circulating placental markers prokineticin-1, soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriage.
    Jayasena CN; Abbara A; Comninos AN; Narayanaswamy S; Gonzalez Maffe J; Izzi-Engbeaya C; Oldham J; Lee TT; Sarang Z; Malik Z; Dhanjal MK; Williamson C; Regan L; Bloom SR; Dhillo WS
    Hum Reprod; 2016 Dec; 31(12):2681-2688. PubMed ID: 27664209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.